- AU$272.31m
- AU$1.20bn
- AU$1.37bn
Australia's Healius eyes best week in 3 months on strategic review, CEO change
Brief: Healius Confirms CFO Appointment
Aussie healthcare stocks jump as insurance premiums rise; Healius top gainer
Australia's Healius jumps most in nearly 4 years as CEO exits amid strategic review
Australia's Healius jumps on review, CEO change amid shareholder value challenges (updated)
Australia's Healius jumps most in nearly 4 years on strategic review, CEO change
Australia's Healius jumps on review, CEO change
Brief: Healius Says Maxine Jaquet Resigns As CEO & Managing Director
Brief: Healius Posts HY Underlying EBITDA Of A$159.1 Million
Australia's Healius up; Macquarie trims PT, earnings view
Brief: Healius Expects Underlying FY 2024 EBITDA Of A$359 Million - A$369 Million
Brief: Healius Announces New Commercial Agreement Between Agilex And SGS S.A.
Australian shares on three-day winning streak; banks, miners lead
E&P Capital initiates on Australian Clinical Labs with 'positive'
Australian healthcare firms to battle cost pressures, soft margins in 2024 - Morgan Stanley
Morgan Stanley cuts rating for Australia's Healius on earnings uncertainty
Australian healthcare stocks on track to end 2023 higher
Brief: Australian Clinical Labs Says Takeover Offer For Healius Limited
Deals of the day-Mergers and acquisitions